AF_AFQ03591F1

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	Complement factor H-related protein 1	opsonin binding protein binding binding complement component C3b binding complement binding identical protein binding	regulation of protein binding regulation of molecular function negative regulation of protein binding regulation of binding negative regulation of binding biological regulation negative regulation of molecular function humoral immune response regulation of biological process response to stimulus immune response positive regulation of biological process immune effector process positive regulation of response to stimulus regulation of protein binding regulation of molecular function negative regulation of protein binding regulation of binding negative regulation of binding biological regulation negative regulation of molecular function humoral immune response regulation of biological process response to stimulus immune response positive regulation of biological process immune effector process positive regulation of response to stimulus complement activation positive regulation of immune response regulation of response to stimulus immune system process regulation of immune response regulation of immune system process positive regulation of immune system process activation of immune response	cellular anatomical structure extracellular region blood microparticle protein-containing complex

Chains	Accession	Name	Type
A	IPR051503	Complement System Regulators and Virion Entry Mediators	Family
A	IPR000436	Sushi/SCR/CCP domain	Domain
A	IPR035976	Sushi/SCR/CCP superfamily	Homologous Superfamily

Chains	Drug Target	Associated Disease
A	: Q03591	IgA glomerulonephritis age related macular degeneration 1 atypical hemolytic-uremic syndrome hemolytic uremic syndrome, atypical, susceptibility to, 1 age-related macular degeneration C3 glomerulonephritis bacterial infectious disease membranoproliferative glomerulonephritis hemolytic-uremic syndrome skin disease dense deposit disease wet macular degeneration

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.